Deep brain stimulation can relieve some of the worst symptoms of Parkinson's disease. Unfortunately, getting the settings just right is like feeling in the dark. Neurologists have to tweak a setting and then ask the patient how it feels. Our new interface made a process once focused on numbers visual, simple and efficient. We deployed a novel technology, to simulate the stimulation area in 3D, to help clinicians predict side effects and fine tune settings without putting the patients through unnecessary pain and discomfort. The promise of technology and elegance of the implementation was enough to entice Boston Scientific to buy Intelect Medical for $60 Million in 2011.
